Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Non Operating Income: 2019-2024

Historic Non Operating Income for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to -$332.9 million.

  • Cellebrite DI's Non Operating Income rose 102.37% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year increase of 106.28%. This contributed to the annual value of -$332.9 million for FY2024, which is 205.97% down from last year.
  • As of FY2024, Cellebrite DI's Non Operating Income stood at -$332.9 million, which was down 205.97% from -$108.8 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Non Operating Income ranged from a high of $119.7 million in FY2022 and a low of -$332.9 million during FY2024.
  • Over the past 3 years, Cellebrite DI's median Non Operating Income value was -$108.8 million (recorded in 2023), while the average stood at -$107.3 million.
  • In the last 5 years, Cellebrite DI's Non Operating Income spiked by 3,042.86% in 2021 and then plummeted by 205.97% in 2024.
  • Over the past 5 years, Cellebrite DI's Non Operating Income (Yearly) stood at $2.2 million in 2020, then surged by 3,042.86% to $68.5 million in 2021, then soared by 74.81% to $119.7 million in 2022, then slumped by 190.88% to -$108.8 million in 2023, then tumbled by 205.97% to -$332.9 million in 2024.